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In response to genotoxic stress, cells evoke
a plethora of physiological responses collec-
tively aimed at enhancing viability andmaintain-
ing the integrity of the genome. Here, we report
that unspliced tRNA rapidly accumulates in the
nuclei of yeast Saccharomyces cerevisiae after
DNA damage. This response requires an intact
MEC1- and RAD53-dependent signaling path-
way that impedes the nuclear export of intron-
containing tRNA via differential relocalization
of the karyopherin Los1 to the cytoplasm. The
accumulation of unspliced tRNA in the nucleus
signals the activation of Gcn4 transcription fac-
tor, which, in turn, contributes to cell-cycle
arrest in G1 in part by delaying accumulation
of the cyclin Cln2. The regulated nucleocyto-
plasmic tRNA trafficking thus constitutes an
integral physiological adaptation to DNA dam-
age. These data further illustrate how signal-
mediated crosstalk between distinct functional
modules, namely, tRNA nucleocytoplasmic
trafficking, protein synthesis, and checkpoint
execution, allows for functional coupling of
tRNA biogenesis and cell-cycle progression.
INTRODUCTION
In order to maintain the fidelity of genetic information,
organisms have evolved surveillance mechanisms that
monitor the integrity of the chromosomes. These con-
served checkpoints comprise a network of regulatory
signaling pathways that initiate downstream events prin-
cipally aimed at repairing DNA lesions, while inducing a
transient arrest in cell division (Weinert and Hartwell,
1988).CCell-cycle progression normally comprises a series of
tightly integrated events initiated via differential activation
of the cyclin-dependent kinases (CDKs). In budding yeast
S. cerevisiae, entry into the cell-division cycle, termed
START, is operationally defined as a point at which cells
become committed to the mitotic cell cycle. This requires
the accumulation of threshold levels of the G1 cyclins Cln1
and Cln2 (Tyers et al., 1992). Activation of the CDK Cdc28
by cyclins signals a host of events that culminate in repli-
cation and the subsequent mitotic segregation of the
chromosomes.
However, several stages in the cell cycle, including the
G1-to-S phase transition, are subject to strict checkpoint
arrest in response to both ectopic and endogenous sour-
ces of DNA damage. The significance of the G1 check-
point arrest is highlighted by the observation that genes
that function in G1 progression, or surveillance mecha-
nisms that monitor its proper execution, are amongst the
most commonly mutated genes found in human cancers
(Sherr and McCormick, 2002).
Progression through the G1 phase is normally tightly
coupled to the rate of active protein synthesis (Polymenis
and Schmidt, 1999). Owing to its ubiquitous requirement
in protein translation, the biogenesis of mature transfer
RNA (tRNA) plays an intrinsic role in this process (Mann
et al., 1992; Volta et al., 2005). After its synthesis by
RNA polymerase III, the primary tRNA transcripts undergo
extensive processing (reviewed in [Hopper and Phizicky,
2003]), which, in the case of intron-containing tRNAs, in-
cludes splicing. The yeast genome encodes 272 tRNA
genes, of which 59, encoding 10 different tRNA species,
contain introns (O’Connor and Peebles, 1991). Splicing
is a prerequisite for the biogenesis of functional tRNA
because all introns disrupt the adjacent anticodon loops.
Although tRNA processing occurs primarily in the nucleus,
splicing in yeast is accomplished in the cytoplasm by
a conserved heterotetrameric complex.
Using yeast as a model system, we report that downre-
gulation of tRNA export represents a previously unantici-
pated physiological response to genotoxic stress. In theell 131, 915–926, November 30, 2007 ª2007 Elsevier Inc. 915
presence of DNA damage, Los1, the principal nuclear ex-
port factor for intron-containing tRNA, becomes differen-
tially localized to the cytoplasm in a signal-dependent
manner. This relocalization causes rapid accumulation of
unspliced precursor tRNA in the nucleus in vivo because
Los1 is limiting for the export process. The nuclear reten-
tion of tRNA autonomously signals the activation of the
Gcn4 transcription factor, which, in turn, mediates the de-
layed accumulation of the key cell-cycle regulator cyclin
Cln2 and the execution of a transient G1 arrest. Disruption
of this regulatory network in null mutants of the upstream
signaling components or the downstream effectors is
associated with aberrant cell-cycle progression and en-
hanced loss of viability after DNA damage.
RESULTS
Downregulation of tRNA Splicing in Response
to DNA Damage
Defects in cellular protein-synthesis machinery (Mann
et al., 1992; Polymenis and Schmidt, 1999), including
those of the tRNA splicing components (Figure S1, see
Supplemental Data available with this article online), are
primarily manifested as a slow G1 progression. Since
DNA damage also elicits a transient G1 arrest, we exam-
inedwhether tRNA processing is subject to regulation dur-
ing checkpoint-induced G1 arrest.
In yeast, the primary tRNA transcript undergoes 50 and
30 end removal in the nucleus and, in intron-containing
species, splicing after export to the cytosol (Figure 1A).
The subsequent ligation of the spliced exons gives rise
to functionally mature tRNA. Wemonitored tRNA end pro-
cessing and splicing by using oligonucleotide probes that
hybridize specifically to the 50 or 30 splicing junctions of
tRNA IleUAU, as a representative tRNA, or to the intron it-
self. The results demonstrate that whereas end process-
ing remains intact, there is an accumulation of intron-
containing, but end-processed, tRNA after treatment
with the DNA alkylating agent methylmethane sulfonate
(MMS) (Figure 1B). The accumulation of this processing in-
termediate is a reflection of an in vivo defect in the splicing
step (O’Connor and Peebles, 1991). To confirm the causal
basis for this effect, we exposed yeast cultures to UV irra-
diation, which induces DNA lesions distinct from those
generated by MMS. Probing tRNAIle revealed a similar de-
fect in splicing in UV-irradiated cells, as seen after MMS
treatment (Figure 1C, upper row).
Since the splicing junctions in intron-containing tRNAs
are not conserved and the introns themselves vary in
sequence and length (Abelson et al., 1998), we similarly
probed several other intron-containing tRNAs to verify
the ubiquity of the DNA-damage response. All newly tran-
scribed tRNA species examined displayed comparable
splicing defects after UV exposure (Figure 1C). The ratio
of end-processed to primary tRNA transcript serves as a
measure of in vivo splicing efficiency (O’Connor and Pee-
bles, 1991). Determining this ratio in tRNAIle and tRNALeu916 Cell 131, 915–926, November 30, 2007 ª2007 Elsevier Inc.before and after DNA damage (Figure 1D) revealed that
the in vivo defect in splicing after UV treatment was not in-
tron specific, was comparable inmagnitude, and occurred
with similar kinetics.
To ensure that the impaired tRNA splicing was not due
to spurious effects of MMS or UV other than generating
DNA lesions, we introduced genomic DNA double-strand
breaks by heterologous expression of the restriction en-
donuclease EcoRI in vivo. A CEN-based plasmid that ex-
presses EcoRI in the presence of galactose is known to
activate DNA damage signaling (Mills et al., 1999). Geno-
mic DNA prepared from yeast cells grown in galactose
that harbor this plasmid display lower average molecular
weights as compared to glucose controls (Figure 2A, up-
per panel), indicating the presence of sporadic DNA dou-
ble-strand breaks. Importantly, these cells also displayed
defective tRNA splicing similar in magnitude (Figure 2A,
lower panel, quantifications at the bottom) to that de-
tected after exposure to UV. Collectively, these data dem-
onstrate that tRNA splicing is impaired in cells with DNA
damage.
The rapid inhibition of tRNA splicing in UV-irradiated
cells (Figure 1D), which was complete within 15 min, indi-
cated that it was not secondary to DNA-damage-induced
cell-cycle arrest since the irradiated cells do not display
a predominant cell-cycle phenotype within this time
course (not shown). Consistent with this, wild-type cells
arrested in early G1 by a-factor treatment exhibited
wild-type splicing activity and, moreover, executed a UV-
induced reduction in tRNA splicing similar to that ob-
served in cycling cells (Figure 2B). The reduction in tRNA
splicing after DNA damage was therefore not a passive
consequence of the induction of cell-cycle arrest.
Downregulation of tRNA Splicing after DNA
Damage Requires an Intact Signaling Pathway
The rapid kinetics of the inhibition of tRNA splicing
(Figure 1D) was highly reminiscent of a signal-mediated
response. Since much of the cellular response to DNA
damage is mediated via conserved checkpoint signaling
pathways, we explored this possibility by evaluating
tRNA splicing after DNA damage in strains bearing null
alleles of select genes encoding core components of the
checkpoint signaling apparatus in yeast. We first exam-
ined in vivo tRNA splicing in strains that harbor deletion
of RAD17, RAD24, or MEC3, which encode interacting
subunits of a protein complex that functions as a DNA le-
sion sensor, and in a strain bearing a null allele of MEC1,
which encodes a distinct sensor that functions in parallel
(Majka and Burgers, 2005; Melo and Toczyski, 2002).
We also examined splicing in amutant harboring a deletion
of RAD53, which encodes the principal downstream sig-
nal transducer.
The rad17, rad24, and mec3 mutants maintained the
ability to downregulate tRNA splicing after MMS treatment
(Figure 2C, left panel), indicating that none of these genes
is singly required for activating this response. In con-
trast, the MMS-treated mec1 or rad53 mutants did not
Figure 1. DNADamage Induces Downre-
gulation of tRNA Splicing
(A) A simplified schematic representation of
tRNA primary transcript processing.
(B) Defective tRNA intron excision in log-phase
cultures of S288Cwild-type yeast in richmedia
(YPD) after MMS treatment (0.04% v/v) for
80 min. Northern blot of the tRNAIle transcript
with probes, denoted by short, thick lines,
complementary to 50 and 30 splice junctions
or to the intron itself. Primary precursor and
end-processed, unspliced transcripts are de-
picted.
(C) Time course analysis of splicing of the
indicated tRNA species after UV irradiation
(60 J/m2).
(D) Quantification of tRNAIle and tRNALeu splic-
ing efficiency after UV exposure. Data were
normalized to untreated controls (not shown);
bars indicate standard deviation across three
independent experiments.accumulate end-processed, intron-containing intermedi-
ates (Figure 2C, right panel), indicating that the perturba-
tion in tRNA splicing after DNA damage was Mec1/
Rad53-dependent.
The requirement for intactMec1andRad53, the sequen-
tial components of a conserved DNA-damage signaling
pathway, indicated that the downregulation of tRNA splic-Cing is an active cellular response. Moreover, the unper-
turbed tRNA splicing activity exhibited by mec1D and
rad53D mutants, which are highly sensitive to DNA dam-
age, indicated that the impaired tRNA splicing activity
exhibited by wild-type cells after exposure to MMS was
not due to a simple loss of cellular viability after genotoxic
stress.Figure 2. Downregulation of tRNA Splic-
ing Requires an Intact Signaling Pathway
(A) Induction of DNA double-strand breaks per-
turbs tRNA splicing. (Top) Genomic DNA from
S288C wild-type cells harboring a galactose-
inducible pGal-EcoRI, expressing the endonu-
clease EcoRI, grown in glucose or galactose,
and stained with ethidium bromide. (Bottom)
tRNAIle splicing, with a probe complementary
to its intron, in cells harboring control (pGal)
or pGal-EcoRI. Ratio of end-processed to pri-
mary unspliced tRNAIle is denoted; control is
assigned an arbitrary value of 1.
(B) MMS (0.04%) reduces tRNAIle splicing in
a-factor-arrested cells. Quantification as in (A).
(C) tRNAIle splicing in select checkpoint mu-
tants exposed to MMS (0.04%) for 80 min.ell 131, 915–926, November 30, 2007 ª2007 Elsevier Inc. 917
Figure 3. Induction of DNA Damage
Specifically Attenuates Nuclear Export
of Intron-Containing tRNA
(A) MMS-induced nuclear retention of precur-
sor tRNA. Log-phase wild-type cells were
treated with 0.04% MMS for 80 min. The
subcellular distribution of intron-containing
tRNAIleUAU transcripts was monitored in situ
by fluorescence microscopy (FITC) by using
a DIG-labeled oligo complementary to its
intron. The nuclei were counterstained with
DAPI.
(B) Quantification of the nucleocytoplasmic
distribution of tRNAIleUAU. The subcellular
abundanceof the tRNAIle transcript in a popula-
tion of cells was determined by quantifying the
FITC signal intensity in the nuclear and cyto-
plasmic compartments (grouped into bins on
the x axis). The number of cells in each bin,
as a percentage of the total cell population
assayed, is plotted on the y axis.
(C) The subcellular distribution of intron-
containing tRNAIleUAU in a rad53D mutant.
(D) Quantification of (C).Checkpoint-Induced Inhibition of tRNA Splicing
Is due to Defective tRNA Nuclear Export
To determine the mechanism underlying the impaired
tRNA splicing after DNA damage, we initially examined if
the defective splicing was due to a reduction in the enzy-
matic activity of the basal tRNA splicing machinery. Using
an in vitro tRNA splicing assay (Reyes and Abelson, 1987)
that provided a qualitative reflection of in vivo splicing ac-
tivity (Figure S2A), lysates prepared fromcontrol untreated
or MMS-treated wild-type yeast displayed comparable
activity over a range of protein concentrations (Fig-
ure S2B). Moreover, the relative abundance of the C-
terminally TAP-tagged enzymatic subunits Sen2 and
Sen34 proteins was unperturbed after DNA damage (Fig-
ure S2C), a finding in line with a previous report showing
that the level of all four SEN gene transcripts remain un-
changed after MMS treatment (Gasch et al., 2001). The
accumulation of unspliced tRNA after DNA damage was
therefore unlikely due to a reduction in the core enzymatic
activity of the tRNA splicing machinery.
Although tRNA is transcribed in the nucleus, the yeast
splicing machinery is localized to the cytoplasm (Yoshi-
hisa et al., 2003). Consequently, mutations in the nuclear
export machinery lead to the accumulation of intron-con-
taining tRNA in the nucleus (Hellmuth et al., 1998; Simos
and Hurt, 1999). Therefore, we monitored the integrity of
tRNA nuclear export after DNA damage. In a fluorescence918 Cell 131, 915–926, November 30, 2007 ª2007 Elsevier Inc.in situ hybridization assay (FISH), the newly transcribed
intron-containing tRNAIle was predominantly localized to
the nucleus during unperturbedgrowth (Figure 3A), a local-
ization pattern in line with what was seen in a previous re-
port (Sarkar and Hopper, 1998). After MMS treatment, the
wild-type cells displayed a more pronounced tRNA nu-
clear accumulation (Figure 3A). We determined the sub-
cellular distribution of intron-containing tRNAIle transcripts
by rigorously quantifying the ratio of nuclear to cytoplas-
mic fluorescence (FITC) signals in a cell population (see
Experimental Procedures for details). This quantitative ap-
proach confirmed that the precursor tRNA is nuclear en-
riched in MMS-treated cells (Figure 3B), thereby illustrat-
ing that the subcellular distribution of tRNA was subject
to fine regulation in cells with DNA damage. The MMS-
induced nuclear retention of newly transcribed tRNA in
situ was correlated with the accumulation of unspliced
tRNA in vivo (Figure 2C, WT). Unlike the wild-type cells,
the rad53mutants did not exhibit differential tRNA nuclear
accumulation after MMS treatment (Figure 3C, quantified
in Figure 3D), in agreement with the observation that these
mutants maintained the ongoing rate of tRNA splicing
after DNA damage (Figure 2C, rad53D). The Rad53-medi-
ated sequestering of precursor transcripts in the nucleus
provided a plausible mechanistic basis for the accumula-
tion of unspliced tRNA in vivo after DNA damage in wild-
type cells.
Figure 4. MMS Treatment Results in Subcellular Redistribution of tRNA Export Factor Los1
(A) In vivo tRNAIleUAU splicing in wild-type and los1D cells harvested 30min after UV irradiation (60 J/m
2) or 80min after MMS (0.04%) treatment. Total
RNA was assayed with an oligo complementary to the tRNAIle intron.
(B) Subcellular distribution of intron-containing tRNAIleUAU in a los1 mutant in situ by fluorescence microscopy as in Figure 3A.
(C) Quantification of the nucleocytoplasmic distribution of tRNAIleUAU as in Figure 3B.
(D) Los1-TAP abundance monitored by western blot of whole-cell lysates from untreated and MMS-treated cells. The mitochondrial porin served as
the loading control.
(E) In situ localization of Los1-GFP in wild-type and rad53D cells before or after MMS exposure (0.04% for 80 min). Successive images for GFP and
DAPI are shown.
(F) Differential recovery of Los1-TAP in cytoplasmic fractions after MMS treatment determined by western blot of the cytosolic fractions and lysates
from Ficol-gradient-purified nuclei. The canonical TATA-box binding protein (TBP) served as a nuclear marker.
(G) In situ localization of C-terminally GFP-tagged Kap111, Kap122, and Rna1 before and after MMS treatment.The defect in nucleocytoplasmic trafficking was not
ubiquitous because two intronless tRNAs, in addition to
poly(A)-containing mRNA, maintained a persistent sub-
cellular localization after MMS treatment (Figure S3). The
intact nucleocytoplasmic trafficking of these RNA species
suggested that the nuclear accumulation of intron-
containing tRNA after MMS was a targeted response, an
observation that is in line with its requirement for a signal-
ing pathway (Figure 2C).
The nuclear accumulation of tRNA after MMS treatment
is not due to elevated synthesis of primary transcripts after
DNA damage, because the polymerase III-directed tRNA
transcription is globally downregulated after DNA damage
in yeast (Ghavidel and Schultz, 2001). This raised the pos-
sibility that the nuclear retention of tRNA was due to its
attenuated export from the nucleus.
As a member of the importin b family of karyopherins,
yeast Los1 (Hopper et al., 1980) and its mammalian coun-
terpart, exportin-t (Arts et al., 1998), are the principal tRNA
export receptors. In keeping with its gross defect in tRNACsplicing in vivo (Figure 4A), los1 deletion mutants dis-
played a constitutive nuclear accumulation of intron-
containing tRNA IleUAU in unperturbed growth (Figure 4B,
quantifications in Figure 4C). However, unlike the wild-
type cells, induction of DNA damage in los1D cells did
not enhance the basal defect in tRNA export (Figure 4C)
or splicing (Figure 4A, quantifications shown at the bot-
tom). The failure to elicit a response in these mutants sug-
gested that the nuclear accumulation of tRNA primary
transcripts in wild-type cells after DNA damage was due
to impaired function of the Los1 export factor.
Western blot of the whole-cell lysates from a strain with
C-terminally TAP-tagged Los1 demonstrated that the ap-
parent involvement of Los1 in defective tRNA export after
DNA damage was not due to a reduction in its relative
abundance (Figure 4D). Given the likelihood of Los1 nucle-
ocytoplasmic shuttling (Hellmuth et al., 1998), we exam-
ined its in situ localization both before and after DNA dam-
age in cells harboring a C-terminally GFP-tagged allele of
LOS1. Similar to its wild-type counterpart (Simos et al.,ell 131, 915–926, November 30, 2007 ª2007 Elsevier Inc. 919
1996), and in keeping with its principal function as an ex-
port factor, Los1-GFP was predominantly localized to the
nuclear periphery during normal growth in wild-type cells
(Figure 4E, left panel). By contrast, a fraction of Los1-
GFP became preferentially redistributed to the cytoplasm
after exposure to MMS, giving rise to its homogenous cel-
lular appearance (Figure 4E, left panel). In an independent
experimental approach, parallel western blot examination
of nuclear and cytosolic protein fractions prepared from
TAP-tagged Los1 cells confirmed the differential relocali-
zation of Los1 to the cytoplasm after MMS exposure
(Figure 4F). In addition to Los1, we also examined the in
situ localization of two other members of the yeast karyo-
pherin b family, Kap111 and Kap122, along with that of
Rna1, a Ran-specific GTPase-activating protein (Ran-
GAP1), involved in RNA export. The apparent persistent
in situ localization of the C-terminally GFP-tagged karyo-
pherins to the nucleus and Rna1 to the cytoplasm (Fig-
ure 4G) suggested that the DNA-damage-induced relocal-
ization of Los1 was a targeted response. Consistent with
this, the nuclear localization of Los1-GFP remained unper-
turbed in MMS-treated rad53D mutants (Figure 4E, right
panel), demonstrating a requirement for Rad53-depen-
dent signaling inmediating this response. The significance
of the DNA-damage-induced Los1 relocalization was
demonstrated by the observation that rad53D cells, which
maintained a constitutive nuclear pool of Los1, displayed
no obvious defect in tRNA export (Figure 3C) or splicing
(Figure 2C) after MMS treatment. Collectively, these data
indicate that the signal-mediated relocalization of Los1
from the nucleus was the likely determinant of the im-
paired tRNA export after DNA damage.
Constitutive Reduction in tRNA Export through
LOS1 Deletion Restores the Impaired G1
Arrest and Enhances the Viability of rad53
Checkpoint Mutants
Delay in progression through theG1 phase of the cell cycle
is a hallmark of cells with unrepaired genomic lesions
(Siede et al., 1994). Although G1 arrest appears to be
a transient delay en route to mitotic arrest, from a theoret-
ical viewpoint, failure to delay cell-cycle progression be-
fore the initiation of DNA replication can lead to gross
chromosomal anomalies (reviewed in Paulovich et al.,
1997b). Accordingly, premature progression through G1
partly accounts for the increased genomic instability in
checkpoint mutants. We therefore examined whether the
failure of rad53 mutants to downregulate tRNA export af-
ter DNA damage (Figure 3D) contributes to the defective
G1 checkpoint execution in these mutants.
As a downstream target of Rad53 signaling (Figure 4E),
LOS1 is functionally epistatic to RAD53 in downregulation
of splicing, because mutation in either gene alone abol-
ishes the MMS-induced reduction in tRNA splicing (Fig-
ures 2C and 4A). We reasoned that deletion of LOS1 in
a rad53 null mutant should functionally mimic its negative
regulation by intact Rad53 signaling in MMS-treated
wild-type cells. This experimental approach is of utility in920 Cell 131, 915–926, November 30, 2007 ª2007 Elsevier Incdeciphering the downstream effectors of signaling path-
ways. For instance, reducinghistonegenedosage, a target
of Rad53-mediated signaling that is normally degraded in
wild-type cells after DNA damage, partially restores viabil-
ity in a rad53mutant (Gunjan and Verreault, 2003).
A constitutive reduction in tRNA splicing via targeted
deletion of LOS1 resulted in marked accumulation of
unspliced tRNA in both rad53D and isogenic wild-type
control strains (Figure 5A,with relative quantifications indi-
cated). In order to examine the integrity of the G1 check-
point in these mutants, logarithmically growing (log) cells
were blocked in G1 with a-factor, treated with MMS,
and then released into freshmedia. Cell-cycle progression
was then monitored by FACS.
In the absence of DNA damage, all four strains dis-
played comparable rates of cell-cycle progression
(Figure 5B, cf. lanes 1, 3, 5, and 7) since arrest in response
to, or recovery from, a-factor arrest is not checkpoint de-
pendent. The MMS-treated wild-type cells displayed a
prolonged G1 progression, indicated by the delay in accu-
mulation of cells with a 2NDNA content (Figure 5B, lanes 1
and 2). The intact Rad53-dependent signaling in wild-type
cells normally impinges on Los1 and alters its nucleocyto-
plasmic distribution (Figure 4E). Accordingly, a los1 null
mutant displayed a G1 delay (Figure 5B, lanes 2 and 4)
and viability (Figure 5C) comparable to that of the wild-
type cells after MMS treatment.
Given the requirement for Rad53 signaling in the G1
checkpoint (Sidorova and Breeden, 1997), the MMS-
treated rad53 null mutant exited G1 unimpeded, indicated
by rapid accumulation of cells with a 2N DNA content (Fig-
ure 5B, cf. lanes 2 and 6). Remarkably, rad53D los1D dou-
ble mutants displayed a G1 profile similar to that of the
wild-type cells (Figure 5B, cf. lanes 2, 6, and 8). In princi-
ple, deletion of LOS1, a negatively regulated downstream
target of Rad53 in wild-type cells, acts as a suppressor of
the defect in G1 checkpoint execution in a rad53 mutant.
Concomitant with the restoration of the G1 checkpoint,
there was a partial recovery in viability in the rad53D
los1D double mutants after MMS treatment relative to
the rad53D parental strain (Figure 5C).
In addition to prolonging G1 progression, treatment of
yeast with MMS also delays DNA replication as a result
of impaired firing of replication origins (Tercero et al.,
2003). Since determining the cellular DNA content by
FACS does not distinguish between slow passage
through START and delayed initiation of replication, we
performed an a-factor trap experiment (Gerald et al.,
2002). Deletion of LOS1 extended the window of a-factor
sensitivity in rad53D los1D double mutants after MMS
treatment, demonstrating that Rad53-mediated downre-
gulation of tRNA export is a determinant of progression
through START (Figure S5).
Downregulation of tRNA Export Contributes
to G1 Arrest by Delaying Translation of Cln2
We sought to examine how impaired tRNA export contrib-
utes to the execution of the G1 checkpoint. In unperturbed.
Figure 5. Deletion of LOS1 Restores G1 Arrest and Enhances Viability in a rad53 Mutant in Response to DNA Damage
(A) tRNAIleUAU splicing in wild-type, los1D, rad53D, and rad53D los1Dmutants assayed by northern blot with an oligo complementary to its intron. The
ratio of end-processed to primary unspliced tRNAIle is denoted; untreated wild-type cells are assigned an arbitrary value of 1.
(B) Delayed G1 progression in rad53Dmutants by deleting LOS1. Logarithmically growing (log) cells were arrested in G1 by a-factor and were treated
with MMS or left untreated. These cells were subsequently released into fresh media and analyzed by FACS.
(C) Reduction in MMS hypersensitivity of rad53Dmutants by deleting LOS1. After MMS treatment, viability was determined by counting colonies after
a 3 day incubation at 30C.growth, the G1 cyclins Cln1, Cln2, and Cln3 largely govern
progression through START (Tyers et al., 1991). In partic-
ular, the accumulation of Cln1 and Cln2 proteins to thresh-
old levels precedes G1 progression. Given the clear delay
in G1 progression in MMS-treated wild-type cells (Fig-
ure 5B, lanes 1 and 2), we explored the possibility that
a defect in the accumulation of the G1 cyclins plays a
role in execution of the G1 checkpoint after DNA damage.
To this end, we monitored the accumulation of Cln2 by
quantitative western blot by using a Cln2-TAP strain
that harbors a C-terminally TAP-tagged allele of CLN2
(Ghaemmaghami et al., 2003). Cln2-TAP cells displayed
wild-type growth rates (data not shown), and the canoni-
cal cell-cycle-regulated expression of Cln2 mRNA and
protein (Figures 6A and 6B, upper panels).
In order to monitor the accumulation of Cln2-TAP after
DNA damage, cells were synchronized in G1 by a-factor
and then left unperturbed or treated with MMS. After re-
lease into fresh media to allow for resumption of the cell
cycle, cells were harvested at the indicated time points,
and whole-cell protein lysates and mRNA were prepared
for analysis (Figures 6A and 6B). Since it was previously
reported that the Cln2 mRNA level decreases after MMS
treatment (Sidorova and Breeden, 1997), we normalized
Cln2-TAP protein abundance to that of its cognate
mRNA in order to monitor the rate of Cln2-TAP protein
translation independent of its transcript levels. Figure 6C
depicts the quantification of Cln2-TAP protein accumula-
tion after release from a-factor arrest. In untreated cells,CCln2-TAP protein steadily accumulated and was maxi-
mally expressed within 40 min after release, whereafter it
declined sharply as cells exited G1 (Figure 5B, lane 1).
By contrast, the accumulation of Cln2-TAP protein was
markedly slower in MMS-treated cells (Figure 6C), coinci-
dent with the delayed G1 progression in these cells (Fig-
ure 5B, lane 2). While we cannot rule out a role for tran-
scriptional regulation of G1 cyclins as part of a broader
cellular response, our data are consistent with the involve-
ment of a posttranscriptional mechanism in regulating
Cln2 expression. Notably, this delay was not due to aber-
rant proteolysis of Cln2 since the half-life of the G1 cyclins
remains unchanged after genotoxic stress (Germain et al.,
1997).
The paralogousCLN1 andCLN2 genes are coordinately
expressed throughout the cell cycle and function redun-
dantly in G1 progression (Tyers et al., 1991). Given their
extensive functional and regulatory overlap, we anticipate
that Cln1 expression is subject to a similar mode of trans-
lational regulation after DNA damage. Despite their appar-
ent functional redundancy, Cln3 is distinct from Cln2 (and
Cln1) both in its primary sequence and largely constitutive
expression pattern throughout the cell cycle (Stuart and
Wittenberg, 1994). Therefore, we monitored the abun-
dance of TAP-tagged Cln3 in parallel. In accordance
with its constitutive cell-cycle expression, Cln3-TAP
levels remained unchanged in a-factor-arrested cells
(Figure S6). Moreover, unlike Cln2-TAP, Cln3-TAP pro-
tein expression was undisturbed in MMS-treated cellsell 131, 915–926, November 30, 2007 ª2007 Elsevier Inc. 921
Figure 6. Impaired tRNA Export Contributes to G1 Checkpoint by Delaying Accumulation of Cln2
(A) Time course analysis of Cln2-TAP accumulation during cell-cycle recovery of wild-type cells after synchronization with a-factor, with or without
exposure to MMS. Porin served as a loading control.
(B) Cln2-TAP and Porin mRNA levels prepared from cells in (A).
(C) Quantification of Cln2-TAP protein, normalized to its cognate mRNA, in unperturbed or MMS-treated cells as depicted in (A) and (B) (see text for
detail).
(D) Cln2-TAP protein levels in control and MMS-treated rad53D or rad53D los1D mutants.
(E) Quantification of Cln2-TAP protein levels depicted in (D).(Figure S6, quantifications in the lower panel). These re-
sults argue for a measure of specificity in the targeted per-
turbation in Cln2 protein translation after DNA damage.
The delayed accumulation of Cln2 in MMS-treated wild-
type cells was highly concordant with the transient G1 ar-
rest in these cells (Figure 5B, lanes 1and 2). Since rad53D
cells do not arrest in G1 after MMS treatment (Figure 5B,
cf. lanes 2 and 6), we reasoned that aberrant Cln2 accu-
mulation may underlie the failure to execute a G1 check-
point in these mutants. We therefore examined Cln2-
TAP protein accumulation in untreated and MMS-treated
rad53D cells after recovery from a-factor arrest.
In contrast to the wild-type cells, Cln2-TAP accumu-
lated in MMS-treated rad53D cells with a kinetic profile
indistinguishable from that observed in untreated cells
(Figure 6D). Since Cln2 accumulation was comparable in
the wild-type and the rad53 mutant during unperturbed
growth, intact Rad53 signaling was specifically required
for the delayed accumulation of Cln2-TAP after DNA dam-
age (Figure 6D, quantification in Figure 6E). Remarkably,
deletion of LOS1 in a rad53 null mutant delayed Cln2-
TAP accumulation after MMS (Figure 6D, quantification
in Figure 6E), while restoring the defective G1 checkpoint
in these cells (Figure 5B, cf. lanes 6 and 8). Collectively,
these data provide evidence that Rad53-dependent regu-
lation of tRNA export plays a key role in executing the G1922 Cell 131, 915–926, November 30, 2007 ª2007 Elsevier Inc.checkpoint by delaying the accumulation of the key cell-
cycle regulator Cln2.
Impaired tRNA Export Contributes to G1
Checkpoint via Activation of GCN4
We sought to examine how the attenuated nuclear export
of intron-containing tRNA contributes to the delayed ac-
cumulation of Cln2 and the subsequent G1 arrest. Since
the delay in Cln2 accumulation is primarily at the transla-
tion level, we reasoned that the defect in tRNA export
leads to impaired translation by lowering the abundance
of the mature tRNA pool available to the protein-synthesis
machinery. Quantitative northern blot, however, revealed
that the defect in flow of the intron-containing transcripts
form the nucleus after UV or MMS treatment had no mea-
surable impact on the level of cognate mature tRNAs
(Figure S7B), a likely reflection of an inordinately long
tRNA half-life (Colby et al., 1981).
Physiological perturbations, such as nutritional or geno-
toxic stress, induce translational derepression of the ubiq-
uitous transcription factor Gcn4, a response conserved
from yeast to mammals (Dever et al., 1993; Engelberg
et al., 1994). Gcn4 activation reduces the rate of general
protein synthesis while simultaneously increasing the ex-
pression of proteins whose functions are required under
conditions of starvation or stress (reviewed in Hinnebusch
Figure 7. Impaired tRNA Export Signals MMS-Induced G1 Arrest by Activating Gcn4
(A) b-galactosidase activity in strains that harbor aGCN4-lacZ reporter plasmid. Logarithmically growing cells, grown in Ura–media, were treatedwith
0.04% MMS for 80 min prior to being processed for b-galactosidase activity, denoted on the x axis (Miller units*101).
(B and C) (B) Time course analysis of Cln2-TAP accumulation during recovery of a wild-type and an isogenic gcn4D strain after synchronization with
a-factor, with or without exposure to MMS. Porin served as a loading control for quantification in (C).
(D) Cell-cycle progression in MMS-treated gcn4Dmutants. Logarithmically growing cells were synchronized in G1 by a-factor and were treated with
MMS or left untreated. These cells were subsequently released into fresh media, and their progression through the cell cycle was monitored at the
indicated time points by FACS.
(E) A working model for regulated nucleocytoplasmic trafficking of tRNA after DNA damage. In cells with DNA damage, a Mec1/Rad53-dependent
signaling pathway, via yet to be identified downstream effector(s), impinges on the export process via differential relocalization of Los1 to the
cytoplasm. The ensuing nuclear accumulation of tRNA signals activation of Gcn4, which, in turn, contributes to the execution of the G1 checkpoint
by delaying the accumulation of cyclin Cln2, and likely other key regulators of G1 progression.and Natarajan, 2002). Remarkably, aberrant tRNA accu-
mulation in the nucleus in mutants with defects in tRNA
processing or export also leads to translational derepres-
sion of Gcn4 in the cytoplasm (Qiu et al., 2000). While
the intermediary components of this response remain
unknown, it is postulated that it serves as a nuclear
surveillance system that detects defects in tRNA biogen-
esis and elicits a Gcn4-dependent reduction in the initia-
tion step of protein translation. In particular, deletion of
LOS1 leads to constitutive activation of Gcn4 (Qiu et al.,
2000). Hence, we investigated whether the less pro-
nounced accumulation of intron-containing tRNA in nuclei
of cells with DNA damage similarly induces activation of
Gcn4.CWe utilized a widely employed CEN-based reporter
plasmid, carrying aGCN4 promoter driving the expression
of a lacZ gene (GCN4-lacZ), that provided a quantitative
measure of Gcn4 activity in a b-galactosidase assay (De-
ver et al., 1992). Wild-type cells that harbor this heterolo-
gous plasmid displayed a basal b-galactosidase activity
in vivo (Figure 7A). MMS treatment led to the expected
Gcn4 activation, reflected in the increase in b-galactosi-
dase activity (Figure 7A). The nearly 3-fold MMS-induced
increase in plasmid-borne lacZ expression was in line with
that in cells that harbor a genomic copy ofGCN4-lacZ (Na-
tarajan et al., 2001).
While rad53D mutants exhibited a level of b-galacto-
sidase activity comparable to that of the wild-type inell 131, 915–926, November 30, 2007 ª2007 Elsevier Inc. 923
unperturbed growth, they did not display the MMS-in-
duced increase in b-galactosidase activity normally seen
in wild-type cells (Figure 7A). Parenthetically, the require-
ment for Rad53 is a salient feature that distinguishes the
MMS-induced response, with respect to upstream signal-
ing, from a general stress response (Figure S8). Moreover,
deletion of LOS1 led to the constitutive activation of Gcn4
and concomitantly abrogated an additional MMS-induced
increase in b-galactosidase activity (Figure 7A). These re-
sults illustrate that Gcn4 activation after MMS treatment
occurred via a regulatory network that minimally com-
prised Rad53 signaling and Los1 as a downstream effec-
tor. It follows that, as with the gross defect in tRNA export
in a los1 null mutant, themore subtle perturbations in tRNA
trafficking also autonomously signaled Gcn4 activation
after DNA damage.
We next examined how the Rad53-mediated activation
of Gcn4 contributes to maintaining homeostasis in cells
with DNA damage. As a downstream effector of Rad53,
deletion of GCN4, similar to that in a rad53 null mutant
(Figure 6D), is expected to result in premature accumula-
tion of Cln2 after MMS treatment, To examine this idea,
wild-type and an isogenic gcn4D mutant that harbor a
TAP-tagged allele of Cln2 were synchronized in G1 by
a-factor treatment and subsequently treated with MMS
prior to release from G1 arrest. While untreated wild-
type and gcn4 strains accumulated Cln2-TAP at compara-
ble rates, accumulation of Cln2-TAP in MMS-treated
gcn4D mutants followed a considerably faster kinetic rel-
ative to that of thewild-type cells (Figure 7B, quantification
in Figure 7C). In line with their premature accumulation of
Cln2-TAP, gcn4D cells also failed to execute a G1 check-
point (Figure 7D), thereby providing an explanation for
their enhanced MMS sensitivity (Begley et al., 2004).
These data illustrate that deletion of GCN4 phenocopies
the G1 checkpoint deficiency normally observed in a
rad53 mutant, consistent with its role as a downstream
component of DNA-damage signaling.
DISCUSSION
As essential components of the protein translation ma-
chinery, tRNAs function as fundamental regulators of cell
growth and proliferation. The primary transcripts of the
noncoding tRNAs are subject to extensive processing,
which belies their apparent functional simplicity. While
the core components of the processing machineries are
well defined, the potential for selective regulation of
tRNA processing in response to biological cues remains
largely unexplored.
Here, we have shown that in budding yeast downregu-
lation of tRNA export constitutes a previously unantici-
pated regulatory mode that contributes to the proper
execution of the G1 checkpoint. Mechanistically, this
response is mediated via Rad53-dependent differential
localization of the Los1 export factor to the cytoplasm in
cells with DNA damage (Figure 4E). This is a compelling
example of a regulatory mechanism that elicits a robust924 Cell 131, 915–926, November 30, 2007 ª2007 Elsevier Inc.cellular response by impinging on Los1, a limiting compo-
nent of the tRNA export (Figure S4). The resulting nuclear
accumulation of unspliced tRNA signals Gcn4 activation
and the subsequent execution of the G1 checkpoint. Fail-
ure to accumulate tRNA after genotoxic stress in rad53
mutants (Figure 3C) contributes to their deficiency in the
G1 checkpoint. Conversely, deletion of LOS1 restores
the G1 checkpoint in a rad53 mutant (Figure 5B, lanes 6
and 8) because it autonomously signals the activation of
Gcn4 (Figure 7A). These data collectively illustrate that
the tRNA export process serves as an entry point for
Rad53 signaling, which serves to transduce information
about the integrity of the genome to the protein-synthesis
machinery in the cytoplasm (Figure 7E). Consistent with its
physiological significance, failure to execute this response
results in elevated loss of viability after DNA damage
(Figure 5C).
Large-scale studies with synthetic genetic arrays (Tong
et al., 2004) and proteomics approaches (Gavin et al.,
2006) have proven highly informative in in vivo mapping
of the components of distinct functional modules in yeast.
However, the potential for concerted regulation of these
modules via their mutual functional interplay remains
largely unknown because these qualitative data primarily
portray static pictures of the cellular protein network to-
pology. The data presented here illustrate a remarkable
signal-mediated crosstalk between distinct functional
modules, namely, tRNA nucleocytoplasmic trafficking,
protein synthesis, and checkpoint execution. It highlights
an interconnecting pathway that contributes to maintain-
ing homeostasis via subtly quantifying the output of these
functional modules. This regulatory network allows for
functional coupling of tRNA biogenesis and cell-cycle
progression, an observation in agreement with the tight
correlation between proliferation rate and cellular protein
synthesis capacity (Niwa and Walter, 2000).
The aberrant tRNA accumulation in the nucleus in cells
with DNA damage temporally precedes and autono-
mously signals G1 arrest via activation of the ubiquitous
transcription factor Gcn4 (Figure 7A). Expression profiling
with cDNA microarray has revealed that Gcn4 activation
is accompanied by wide-spread reorganization of the
cellular transcriptome (Hinnebusch and Natarajan, 2002).
The remodeling of the cellular transcriptional outlook
by Gcn4 likely underlies its function in the G1 checkpoint.
Genes encoding ribosomal proteins and general transla-
tion factors constitute the largest functional cluster among
the genes repressed by Gcn4 (Natarajan et al., 2001). This
partly accounts for the robust reduction in global protein
translation in cells with DNA damage. Recovery from
a DNA-damage-induced G1 arrest, unlike resumption of
the cell cycle after a-factor arrest, requires de novo protein
translation (Siede et al., 1994). The Gcn4-mediated de-
crease in the output of the protein-synthesis machinery
provides a rationale for the differential requirement for
Gcn4 in the G1 checkpoint (Figure 7D).
The temporal requirement for protein synthesis in G1
progression is largely due to a requirement for an efficient
rate of protein synthesis in translation of G1 cyclins (Poly-
menis and Schmidt, 1999). Delayed translation of Cln2 is
correlated with a G1 arrest after MMS exposure in wild-
type cells (Figure 6A). Conversely, aberrant accumulation
of Cln2 is concomitant with premature G1 progression in
MMS-treated null mutants of RAD53 (Figure 5B) and its
downstream effector GCN4 (Figure 7D). Consistent with
a role for translational regulation of Cln2 in executing the
G1 checkpoint, reducing the rate of Cln2 protein accumu-
lation, by deleting LOS1, restoresMMS-induced G1 arrest
(Figure 5B, lanes 6 and 8) and enhances viability in
a checkpoint-defective rad53 mutant (Figure 5C). These
data collectively reiterate the fundamental role of delayed
Cln2 translation in the execution of the G1 checkpoint and
further provide a plausible mechanistic basis for its execu-
tion (Figure 7E). Arguing for the conservation of the Cln2
function in the G1 checkpoint in higher eukaryotes, pre-
mature G1 progression via deregulated expression of G1
cyclin E in human epithelial cells is accompanied by in-
creased loss of genomic stability, an observation in line
with the elevated expression of cyclin E in a host of human
tumors (Spruck et al., 1999).
EXPERIMENTAL PROCEDURES
Yeast Strains
All rad mutant strains were haploid isogenic derivatives of the wild-
typeYMP10860: MATa ura3 leu2 trp1 his3 sml1 (Paulovich et al.,
1997a). C-terminally TAP- and GFP-tagged fusion strains, all deriva-
tives of S288C, were as described (Ghaemmaghami et al., 2003;
Huh et al., 2003). Haploid yeast strains that harbor conditionally
repressible tet alleles of the splicing endonucleases (Mnaimneh
et al., 2004) were grown in YPD and were transferred to fresh YPD +
10 mg/ml doxycycline at 30C for 12 hr in order to shut off expression
from the tet promoters. LOS1 was disrupted with a CloneNAT-select-
able cassette by using a standard one-step integration procedure
(Wach et al., 1994).
Induction of DNA Damage
Unless indicated otherwise, replicate cultures of log-phase cells in
YPD media were treated with 0.04% MMS (Sigma Aldrich) for
80 min. For UV treatment, 30 ml cultures were grown to an A600 of
0.2 in minimal SDmedia and were irradiated for 60 s with a 254 nm ger-
micidal UV lamp at the dose rate of 1 J/m2/s while being stirred in a
15 cmPetri dish (Ghavidel and Schultz, 2001). Viability was determined
by the number of colonies normalized to that observed with untreated
controls after 3 days of incubation at 30C. TheCEN-based expression
plasmid that harbors the restriction endonucleaseEcoRI under a galac-
tose-inducible GAL promoter was as described (Mills et al., 1999).
RNA Preparation and Analysis
Total yeast RNA were isolated and analyzed as described (Schmitt
et al., 1990). Northern blot procedure, including the sequence for indi-
vidual oligonucleotide probes used for detecting select tRNA species,
are as reported (O’Connor and Peebles, 1991).
Protein Preparation and Analysis
Pelleted cells were disrupted with glass beads in lysis buffer (20 mM
HEPES-KOH [pH 7.6], 120 mM ammonium sulfate, 1 mM EDTA, prote-
ase inhibitor cocktail [Roche], 2 mM DTT) with a single 30 s burst with
a mini-bead beater (Biospec). After adding Triton X-100 to 0.25% (v/v),
the lysate was incubated on ice for 30min. Cellular debris was pelleted
by microcentrifugation for 10 min. The protein supernatant wasCresolved in denaturing gels and examined by western blot essentially
as described (Ghavidel and Schultz, 2001).
In Vitro tRNA Splicing Assay
The in vitro splicing assay, performed with a tRNAPhe substrate, was
done essentially as described (Reyes and Abelson, 1987), with slight
modifications as described in Supplemental Data.
Fluorescence Microscopy
The RNA in situ localization (FISH) was done as described (Sarkar and
Hopper, 1998). The quantification scheme for tRNA nucleocytoplas-
mic abundance is described in detail in Supplemental Data.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and eight figures and can be found with this article online at http://
www.cell.org/cgi/content/full/131/5/915/DC1/.
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